Minimally invasive heart valve repair in a beating heart
11589989 · 2023-02-28
Assignee
Inventors
Cpc classification
A61B17/0469
HUMAN NECESSITIES
A61B2017/048
HUMAN NECESSITIES
A61B17/0487
HUMAN NECESSITIES
A61B2017/0488
HUMAN NECESSITIES
A61B2017/00694
HUMAN NECESSITIES
A61B2017/00349
HUMAN NECESSITIES
A61B17/0625
HUMAN NECESSITIES
International classification
A61B17/04
HUMAN NECESSITIES
A61B17/06
HUMAN NECESSITIES
A61F2/24
HUMAN NECESSITIES
Abstract
In one embodiment, a method of repairing a heart valve accesses an interior of a patient's beating heart minimally invasively and inserts one or more sutures into each of a plurality of heart valve leaflets with a suturing instrument. The suture ends of the sutures are divided into suture pairs, with each pair including one suture end from a suture inserted into a first valve leaflet and one suture end from a suture inserted into a second valve leaflet. One or more tourniquet tubes is advanced over the suture pairs to the leaflets to draw the sutures together to coapt the leaflets and then the sutures are secured in that position.
Claims
1. A system for minimally invasively performing an edge to edge heart valve leaflet repair on a beating heart of a patient, comprising: a suturing device configured to grasp and stabilize each of a first valve leaflet and a second valve leaflet to minimally invasively insert one or more sutures into each of the first valve leaflet and the second valve leaflet of a heart valve in the beating heart of a patient, each suture having a pair of suture ends; a tourniquet tube configured to be advanced towards the heart valve over a plurality of suture pairs such that the sutures are drawn into a coaptation tension in which the first valve leaflet and the second valve leaflet are in a coapted position, wherein each suture pair includes one of the pair of suture ends of a suture inserted through the first valve leaflet and one of the pair of suture ends of a suture inserted through the second valve leaflet; and means for securing the sutures with the sutures in the coaptation tension, wherein the tourniquet tube is configured to be withdrawn from the suture ends following securement of the sutures, and wherein the suture ends are configured to be anchored at a wall of the heart with the sutures in the coaptation tension.
2. The system of claim 1, wherein further comprising a ligature suture having a suture loop configured to be advanced along the tourniquet tube to the first valve leaflet and the second valve leaflet and secured around the sutures with the sutures in the coaptation tension.
3. The system of claim 2, wherein the suture loop is configured to be advanced along the tourniquet tube along an exterior of the tourniquet tube.
4. The system of claim 2, where the suture loop is configured to be advanced along the tourniquet tube along an interior of the tourniquet tube.
5. The system of claim 1, wherein the tourniquet tube has a clip at a distal end of the tourniquet tube configured to be disconnected from a body portion of the tourniquet tube and secured around the sutures.
6. The system of claim 5, wherein the body portion of the tourniquet tube is configured to be rotated in a first direction to secure the clip around the sutures and rotated in a second direction opposite of the first direction to disconnect the clip from the body portion.
7. The system of claim 1, wherein the tourniquet tube is a single tourniquet tube configured to be advanced over all suture pairs.
8. The system of claim 1, wherein the tourniquet tube comprises a thin plastic tube.
9. A system for minimally invasively performing an edge to edge heart valve leaflet repair on a beating heart of a patient, comprising: a suturing device configured to minimally invasively insert one or more sutures into each of a first valve leaflet and a second valve leaflet of a heart valve in the beating heart of a patient, each suture having a pair of suture ends; a tourniquet tube configured to be advanced towards the heart valve over a plurality of suture pairs such that the sutures are drawn into a coaptation tension in which the first valve leaflet and the second valve leaflet are in a coapted position, wherein each suture pair includes one of the pair of suture ends of a suture inserted through the first valve leaflet and one of the pair of suture ends of a suture inserted through the second valve leaflet; and means for securing the sutures with the sutures in the coaptation tension, wherein the tourniquet tube is configured to be withdrawn from the suture ends following securement of the sutures, and wherein the suture ends are configured to be anchored at a wall of the heart with the sutures in the coaptation tension, and further comprising a plurality of tourniquet tubes including a separate tourniquet tube for each suture pair.
10. A system for minimally invasively performing an edge to edge heart valve leaflet repair on a beating heart of a patient, comprising: a suturing device configured to grasp and stabilize each of a first valve leaflet and a second valve leaflet to minimally invasively insert one or more sutures into each of the first valve leaflet and the second valve leaflet of a heart valve in the beating heart of a patient, each suture having a pair of suture ends; a tourniquet tube configured to be advanced towards the heart valve into contact with the first valve leaflet and the second valve leaflet over a plurality of suture pairs such that the one or more sutures in the first valve leaflet and the one or more sutures in the second valve leaflet are drawn into a coaptation tension by the tourniquet tube in which the first valve leaflet and the second valve leaflet are in a coapted position, wherein each suture pair includes one of the pair of suture ends of a suture inserted through the first valve leaflet and one of the pair of suture ends of a suture inserted through the second valve leaflet; and wherein the tourniquet tube is configured to be withdrawn from the suture ends following securement of the sutures at the coaptation tension, and wherein the suture ends are configured to be anchored at a wall of the heart with the sutures in the coaptation tension.
11. The system of claim 10, wherein further comprising a ligature suture having a suture loop configured to be advanced along the tourniquet tube to the first valve leaflet and the second valve leaflet and secured around the sutures with the sutures in the coaptation tension.
12. The system of claim 11, wherein the suture loop is configured to be advanced along the tourniquet tube along an exterior of the tourniquet tube.
13. The system of claim 11, where the suture loop is configured to be advanced along the tourniquet tube along an interior of the tourniquet tube.
14. The system of claim 10, wherein the tourniquet tube has a clip at a distal end of the tourniquet tube configured to be disconnected from a body portion of the tourniquet tube and secured around the sutures.
15. The system of claim 14, wherein the body portion of the tourniquet tube is configured to be rotated in a first direction to secure the clip around the sutures and rotated in a second direction opposite of the first direction to disconnect the clip from the body portion.
16. The system of claim 10, further comprising a plurality of tourniquet tubes including a separate tourniquet tube for each suture pair.
17. The system of claim 10, wherein the tourniquet tubes is a single tourniquet tube configured to be advanced over all suture pairs.
18. The system of claim 10, wherein the tourniquet tube comprises a thin plastic tube.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17) While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications equivalents, and alternatives falling within the spirit and scope of the invention.
DETAILED DESCRIPTION
(18) A mitral valve is schematically depicted in
(19) Under normal cardiac conditions, the left atrium contracts and forces blood through the mitral valve and into the left ventricle. As the left ventricle contracts, hemodynamic pressure forces the mitral valve shut and blood is pumped through the aortic valve into the aorta. For the mitral valve to shut properly, the valvular edges of the valve leaflets must form a non-prolapsing seal, or coaptation, that prevents the backflow of blood during left ventricular contraction.
(20) A properly functioning mitral valve opens and closes fully. When the mitral valve fails to fully close, as depicted in
(21) When blood regurgitates from the left ventricle into the left atrium, such as due to MR, less blood is pumped into the aorta and throughout the body. In an attempt to pump adequate blood to meet the blood needs of the body, the left ventricle tends to increase in size over time to compensate for this reduced blood flow. Ventricular enlargement, in turn, often leads to compromised contractions of the heart, thereby exacerbating the congestion of blood within the lungs. If left untreated, severe MR can eventually lead to serious cardiac arrhythmia and/or congestive heart failure (CHF).
(22) Mitral valve regurgitation can be caused by any number of conditions, including mitral valve prolapse (a condition in which the leaflets and chordae tendineae of the mitral valve are weakened resulting in prolapse of the valve leaflets, improper closure of the mitral valve, and the backflow of blood within the heart with each contraction of the left ventricle), damaged chords (wherein the chordae tendineae become stretched or ruptured, causing substantial leakage through the mitral valve), ventricular enlargement, rheumatic fever (the infection can cause the valve leaflets to thicken, limiting the valve's ability to open, or cause scarring of the leaflets, leading to regurgitation), endocarditis (an infection inside the heart), deterioration of the mitral valve with age, prior heart attack (causing damage to the area of the heart muscle that supports the mitral valve), and a variety of congenital heart defects. As MR becomes exacerbated over time, the condition can become more severe, resulting in life-threatening complications, including atrial fibrillation (an irregular heart rhythm in which the atria beat chaotically and rapidly, causing blood clots to develop and break loose and potentially result in a stroke), heart arrhythmias, and congestive heart failure (occurring when the heart becomes unable to pump sufficient blood to meet the body's needs due to the strain on the right side of the heart caused by fluid and pressure build-up in the lungs).
(23) The present application describes various devices and methods that can be employed on the beating heart of a patient in a minimally invasive manner to treat mitral valve regurgitation as described above. Embodiments as described herein can be used to restrain a prolapsing leaflet to prevent leaflet prolapse and to promote leaflet coaptation. According to certain embodiments, the present invention generally reduces the need to perform an edge to edge valve repair with a suture with a sternotomy and cardiopulmonary bypass surgery. Specifically, the present invention can provide a minimally invasive edge to edge treatment of MR. This treatment significantly decreases trauma to surgical patients by facilitating transapical access of a beating heart via a lateral thoracotomy in a manner that eliminates certain surgical steps normally required to complete mitral valve repair procedure by sternotomy.
(24) In certain embodiments, the methods described herein are performed via transapical access. Transapical access to a heart includes all entry points that are within approximately the bottom third of the heart. As used in this patent application, transapical access to a heart includes all directions of entry and points of entry, as well as all angles of entry at each entry point. Further details regarding such access can be found in PCT Publication No. WO 2006/078694 to Speziali, which is hereby incorporated herein by reference in its entirety. In other embodiments, the methods can be performed via an endovascular approach, such as a transfemoral, transeptal approach. Further details regarding such an endovascular access approach can be found in U.S. Patent Publication No. 2016/014737, which is hereby incorporated by reference in its entirety.
(25) One embodiment of an instrument 10 that can be used in performing the methods described herein is depicted in
(26) Located on the distal, intracardiac end 140 of the instrument 10 is a grasping mechanism which can be operated to hold a valve leaflet. As shown in
(27) Disposed in a needle lumen 164 formed in the shaft 100 is a needle 180 which connects to the control shaft 122 at the proximal end of shaft 100. Needle mechanism 180 slides between a retracted position in which it is housed in the lumen 164 near the distal end of the shaft 100 and an extended position in which it extends into the sliding tip 160 when the tip is in its closed position. As a result, if a valve leaflet has been captured between the tip 160 and the distal end of shaft 100 the needle may be extended from the lumen 164 by moving control shaft 122 to puncture the captured leaflet and pass completely through it.
(28) The distal end of the shaft 100 can also contain an artificial chorda, or suture 18 that is to be deployed in the patient's heart. The suture 18 is typically a 4-0 or 5-0 suture manufactured by a company such as Gore-Tex. This suture 18 is deployed by the operation of the grasping mechanism and the needle mechanism 180 as described in more detail below.
(29) The shaft 100 has a size and shape suitable to be inserted into the patient's chest and through the left ventricle cardiac wall and form a water-tight seal with the heart muscle. It has a circular or ellipsoidal cross-section and it houses the control links between the handle end and the intracardiac end of the instrument as well as a fiber optic visualization system. Further details regarding example embodiments of such devices can be found in U.S. Pat. Nos. 8,465,500; 8,758,393; and 9,192,374, each of which is hereby incorporated by reference herein in its entirety.
(30) As shown in
(31)
(32) Referring to
(33) Referring now to
(34) As can be seen in
(35) The tourniquet tubes 25A-25D are then withdrawn from the sutures 18A-18D and each of the suture pairs 23A-23D and the ligature suture 35 are tied off at the access point 13 at the apex 12 of the heart as shown in
(36) Referring now to
(37) As noted above, one benefit of utilizing tourniquet tubes as described herein is to minimize interference with internal structure of the heart. To this end, tourniquet tubes are preferably provided with a minimal external form factor while still providing an opening into which sutures can be easily inserted. Individual tourniquet tubes 25A-25D can, for example, each have an outer diameter between about 2 mm to about 10 mm and an inner lumen having a diameter between about 1 mm to about 8 mm. A single tourniquet tube 25 utilized for all suture pairs can, for example, have an outer diameter between about 2 mm and about 10 mm and an inner lumen having a diameter between about 1 mm and about 8 mm. The length of any given tourniquet tube can, for example, be between about 10 mm and about 15 mm.
(38) In a further embodiment depicted in
(39)
(40) The sutures are then divided into suture pairs at step 206, with each suture pair consisting of one suture end extending from a suture inserted through a first valve leaflet, such as the anterior leaflet of the mitral valve, and one suture end extending from a suture inserted through a second valve leaflet, such as the posterior leaflet of the mitral valve. One or more small tourniquet tubes can then be inserted over the sutures pairs at step 208. As described above, in various embodiments each suture pair can be provided with an individual tourniquet tube or a single tourniquet tube can be utilized for all suture pairs. A stabilizing device such as a mosquito forceps can optionally be used at step 210 to stabilize the tourniquet tube(s) on the suture pairs prior to advancing the tourniquet tube(s) along the suture pairs up to the leaflets at step 212 to draw the sutures together to coapt the leaflets. The tourniquet tube(s) and sutures can then be secured with the forceps clamping the tourniquet tube(s) and sutures in relative position to each other. Proper valve function can be confirmed using real-time transesophageal echocardiography. A ligature assembly is then advanced to the leaflets at step 214 and its suture loop tightened around the sutures to secure the sutures at the appropriate tension to maintain the leaflets in an edge to edge, coapted configuration at step 216.
(41) As described above, in various embodiments the ligature assembly can be advanced from around the one or more tourniquet tube(s) or within a single tourniquet tube. As also described above, in various embodiments a single stabilizing tourniquet having an attached clip or suture loop can be employed in place of separate tourniquet tube(s) and ligature assembly. After the ligature suture loop (or clip) has been secured, the tourniquet tube(s) can then be withdrawn at step 218. The sutures through the leaflets and/or ligature suture are then tied off and the access point to the heart closed at step 220. The valve leaflets will therefore remain in a coapted, edge to edge position maintained by the tensioned sutures, preventing leaflet prolapse and valve regurgitation.
EXAMPLE
(42) Transapical edge to edge mitral valve repair consistent with the above-described embodiments was performed and proven safe and efficacious in a patient with isolated P2 scallop flail/prolapse. The repair was performed to treat bileaflet commissural prolapse as a solution for a patient not considered appropriate for any other approved transcatheter repair. The patient was 72 years old and had previously had multiple left thoracotomies to treat recurrent pneumothorax presented with progressive dyspnea and New York Heart Association (NYHA) Functional Class III. Echocardiography demonstrated severe paracommissural mitral valve regurgitation. Multi-slice computed tomography demonstrated a severe calcification of the A1, P1, and P2 annular segments of the valve.
(43) The procedure was performed under general anesthesia with standard postero-lateral ventricular access, using guidance from transesophageal echocardiography (2-D and 3-D TEE). Three sutures were implanted on the posterior leaflet (P2-P3) and three on the anterior leaflet (A2-A3). After implantation, coaptation of the two leaflets was achieved by putting tension on all of the sutures together with a tourniquet tube. Once stable coaptation was achieved, all sutures were tightened at the base of the ventricular edge of the leaflets using a ligature loop assembly (Surgitie Loop by Covidien) that was advanced over the tourniquet under echo guidance. Once the loop was secured, the tourniquet was removed, the ventricular purse string access was closed, and the sutures through the leaflets and the end of the ligature suture were fixed on the epicardium surface. The patient was discharged and at a one month follow up was asymptomatic (NYHA Functional Class I) with mild to moderate MR, confirmed by echocardiograhpic and multi-slice computed tomography.
(44) Although specifically described with respect to the mitral valve, it should be understood the devices described herein could be used to treat any other malfunctioning valve, such as the tricuspid and aortic valves. Further, although not specifically described herein, it should be understood that the devices described in the present application could be implanted into the beating heart of the patient via various access approaches known in the art, including transapical approaches (e.g., through the apex of the left ventricle) and transvascular approaches, such as transfemorally (through the femoral vein). One example of a transapical access approach that could be employed is described in U.S. Pat. No. 9,044,221, previously incorporated by reference herein. One example of a transvascular access approach that could be employed is described in U.S. Patent Publication No. 2013/0035757, previously incorporated by reference herein. This versatility in access approach enables the access site for the procedure to be tailored to the needs of the patient.
(45) Various embodiments of systems, devices, and methods have been described herein. These embodiments are given only by way of example and are not intended to limit the scope of the present invention. It should be appreciated, moreover, that the various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, implantation locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the invention.